LBL.H — Lattice Biologics Balance Sheet
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual balance sheet for Lattice Biologics, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2016 September 30th | 2017 September 30th | 2018 September 30th | 2019 September 30th | 2020 September 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | fx Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.041 | 0.019 | 0.006 | 0.016 | 0.057 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.323 | 0.217 | 0.171 | 0.264 | 0.29 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 2.12 | 2.09 | 1.68 | 1.04 | 0.902 |
| Net Property, Plant And Equipment | 0.516 | 0.337 | 0.505 | 0.492 | 1.51 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Total Assets | 3.52 | 3.45 | 3.07 | 2.27 | 3.02 |
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 5.93 | 6.53 | 6.97 | 7.68 | 7.83 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 8.01 | 7.71 | 8.39 | 8.59 | 9.42 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | -4.49 | -4.26 | -5.32 | -6.31 | -6.4 |
| Total Liabilities & Shareholders' Equity | 3.52 | 3.45 | 3.07 | 2.27 | 3.02 |
| Total Common Shares Outstanding |